Skip to main content

Table 1 Univariate and multivariate proportional hazards analyses linking SULF2 expression to prognosis in HM cohort

From: SULFs in human neoplasia: implication as progression and prognosis factors

HM cohort (OS)

 

Pronostic variable

Proportional hazard ratio

P-value

Univariate

Cox analysis

SULF2

ISS

4.08

1.73

0.007

0.001

Multivariate

Cox analysis

SULF2

ISS

3.65

1.70

0.028

0.001

Univariate

Cox analysis

SULF2

b2M

Alb

4.08

1.10

1.60

0.007

0.0001

0.04

Multivariate

Cox analysis

SULF2

b2M

Alb

3.49

1.10

1.35

0.03

0.0001

0.24

Univariate

Cox analysis

SULF2

HRS

4.08

2.30

0.007

0.002

Multivariate

Cox analysis

SULF2

HRS

4.11

2.31

0.01

0.002

Univariate

Cox analysis

SULF2

MS group

4.08

2.14

0.007

0.001

Multivariate

Cox analysis

SULF2

MS group

3.84

1.97

0.023

0.028

Univariate

Cox analysis

SULF2

IFM score

4.08

3.09

0.007

0.0001

Multivariate

Cox analysis

SULF2

IFM score

4.29

3.22

0.014

0.0001

Univariate

Cox analysis

SULF2

GPI

4.08

2.21

0.007

0.0001

Multivariate

Cox analysis

SULF2

GPI

4.47

2.25

0.011

0.0001

Univariate

Cox analysis

SULF2

MYEOV

4.08

3.16

0.007

0.05

Multivariate

Cox analysis

SULF2

MYEOV

3.71

2.76

0.026

0.08

Univariate

Cox analysis

SULF2

CD200

4.08

2.05

0.007

0.03

Multivariate

Cox analysis

SULF2

CD200

3.86

1.03

0.02

0.05

  1. Univariate analyses were done to screen for prognostic variables linked to SULF2 expression using Cox proportional hazards regression. The Cox model was also used for multivariate analysis to identify the most significant variables related to survival (OS): ISS (international staging system), b2M (beta-2 microglobulin), Alb (Albumin), HRS (High Risk Score), MS group (MMSET group), IFM score (IFM score), GPI (Growth Proliferation Index), MYEOV and CD200. P-values are in bold and italic when a significant result was obtained (p < 0.05).